Current position:Home >Product >
Glycerides, tallow mono- and di-, esters with propylene glycol (1:1), ethoxylated
Glycerides, tallow mono- and di-, esters with propylene glycol (1:1), ethoxylated(68606-20-2)
- Name: Glycerides, tallow mono- and di-, esters with propylene glycol (1:1), ethoxylated
- Synonyms:
- Molecular Formula:
- Molecular Weight:
- CAS Registry Number:68606-20-2
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.68606-20-2 Glycerides, tallow mono- and di-, esters with propylene glycol (1:1), ethoxylated
Assay:99% Package:according to customer requirements Transportation:By Sea/Air/Courier Application:It is an important raw material.
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.68606-20-2 Glycerides, tallow mono- and di-, esters with propylene glycol (1:1), ethoxylated
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:Glycerides, tallow mono- and di-, esters with propylene glycol (1:1), ethoxylated
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
Other Product
- 25173-82-4/(2-hydroxyphenyl)(phenyl)acetic acid
- 7066-46-8/N-{4-hydroxy-2,3-dimethyl-5-[(4-methylphenyl)sulfonyl]phenyl}-4-methyl-N-[(4-methylphenyl)sulfonyl]benzenesulfonamide
- 71230-79-0/Poly(difluoromethylene),a,a',a''-[1,2,4-benzenetriyltris[carbonyloxy(2-iodo-3,1-propanediyl)]]tris[w-fluoro-
- 147883-81-6/MSE55 protein
- 6278-33-7/2-(morpholin-4-yl)-1-phenylhexan-1-ol
- 71932-97-3/4-ethylhex-2-ynal
- 93980-98-4/2-[[4-chloro-6-isopropoxy-1,3,5-triazin-2-yl]amino]-5-[[1-ethyl-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-(sulphomethyl)-3-pyridyl]azo]-benzene-1,4-disulphonic acid
- 66580-73-2/N-hexanoylchitosan
- 1903-29-3/2-cycloheptylideneacetic acid
- 21210-06-0/platinum(2+) chloride 2-[(2-aminoethyl)amino]ethanol (1:2:2)
- 26179-13-5/(2E)-5-[(3-methoxyphenyl)hydrazono]-4-phenyl-1,3-thiazol-2(5H)-imine
- 84261-43-8/3-ETHYL-4-HYDROXY-1-PHENYLQUINOLIN-2(1H)-ONE
- 84000-70-4/2,2'-[azobis[[1,1'-biphenyl]-4,4'-diyl]]bis[anthra[2,1-d]oxazole-6,11-dione]
- 110241-33-3/Chol-8-en-24-oic acid,3,7,15-trihydroxy-4,4,14-trimethyl-11-oxo-, (3b,5a,7a,15a)- (9CI)
- 127888-94-2/Insulin, mixt. withsodium selenite (2:1) and transferrins
- 138704-11-7/Acetamide,N-[(5S)-6,7-dihydro-2,10-dihydroxy-3,9,11-trimethoxy-5H-dibenzo[a,c]cyclohepten-5-yl]-
- 82627-73-4/(4Z,5E)-1-(4-methoxyphenyl)-4,5-bis[(4-methoxyphenyl)imino]-3-methylimidazolidine-2-thione
- 62213-20-1/Pyrophosphatase,cytidine diphosphodiacylglycerol (9CI)
- 5436-32-8/[(E)-(4-methoxyphenyl)diazenyl]propanedinitrile
- 68606-20-2/Glycerides, tallow mono- and di-, esters with propylene glycol (1:1), ethoxylated
- 2387-79-3/3H-3a,7-Methanoazulen-2-ol,2,4,5,6,7,8-hexahydro-1,4,9,9-tetramethyl-, (3aR,4R,7R)-
- 85168-87-2/1-(2,2-dimethoxyethoxy)butane
- 87669-67-8/6,8-dichloro-3-methyl-3-(piperidin-1-ylmethyl)-2,3-dihydro-4H-chromen-4-one
- 82457-11-2/Chromate(1-),[3-[4,5-dihydro-4-[2-[2-(hydroxy-kO)-5-nitrophenyl]diazenyl-kN1]-3-methyl-5-(oxo-kO)-1H-pyrazol-1-yl]benzenesulfonamidato(2-)][4-(hydroxy-kO)-3-[2-[2-(hydroxy-kO)-1-naphthalenyl]diazenyl-kN1]benzenesulfonamidato(2-)]-,hydrogen (1:1)
- 6295-88-1/1-[(2,4,6-trinitrophenyl)amino]pyridinium
- 188846-23-3/5,10b:11,4b-Bis(iminoethano)dibenzo[c,h][2,6]naphthyridine,5,6-dihydro-13,18-dimethyl-, (4bS,5R,10bS)- (9CI)
- 7469-22-9/phenyl(4-phenylcyclohexyl)methanone
- 34617-32-8/[2R-[2R*(4R*,8R*)]]-3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl 2-acetoxybenzoate
- 65086-69-3/9,12-Octadecadienoic acid (9Z,12Z)-, dimer, compd. with alpha,alpha-(((9Z)-9-octadecenylimino)di-2,1-ethanediyl)bis(omega-hydroxypoly(oxy-1,2-ethanediyl)) (1:1)
- 74203-44-4/(1R,5S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate - 1-phenylpropan-2-amine (1:1)